No known inactivating mutations in DDR genes were observed in patients’ biopsy samples except for patient 1 whose cancer harbored a germline frameshift mutation in BRCA1 (data not shown) without loss of heterozygosity, suggesting at least partial HR proficiency. The gene discussed is BRCA1; the disease is cancer.